Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.44 USD | -5.23% | -21.61% | +93.59% |
May. 09 | Black Diamond Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 11 | Black Diamond Therapeutics, Inc. Announces Board and Committee Changes | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 286M |
---|---|---|---|---|---|
Net income 2024 * | -81M | Net income 2025 * | -110M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-3.77
x | P/E ratio 2025 * |
-3.39
x | Employees | 54 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.68% |
1 day | -5.23% | ||
1 week | -21.61% | ||
Current month | -2.33% | ||
1 month | +4.21% | ||
3 months | +7.51% | ||
6 months | +141.78% | ||
Current year | +93.59% |
Managers | Title | Age | Since |
---|---|---|---|
Elizabeth Buck
FOU | Founder | 49 | 13-12-31 |
Mark Velleca
CEO | Chief Executive Officer | 60 | 21-08-08 |
David Epstein
FOU | Founder | 65 | 13-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Epstein
FOU | Founder | 65 | 13-12-31 |
Mark Velleca
CEO | Chief Executive Officer | 60 | 21-08-08 |
Ali Behbahani
BRD | Director/Board Member | 47 | 18-11-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-15 | 5.44 | -5.23% | 2,527,228 |
24-05-14 | 5.74 | -3.37% | 412,612 |
24-05-13 | 5.94 | -2.78% | 424,240 |
24-05-10 | 6.11 | -9.48% | 547,161 |
24-05-09 | 6.75 | -2.74% | 652,124 |
Delayed Quote Nasdaq, May 15, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+93.59% | 302M | |
+7.52% | 111B | |
+11.38% | 106B | |
-12.64% | 22.24B | |
+0.44% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-8.58% | 16.81B | |
+37.41% | 12.54B | |
-23.95% | 8.09B |
- Stock Market
- Equities
- BDTX Stock